CINQAIR® (reslizumab) Injection – About Asthma Control
How patients use CINQAIR® (reslizumab) Injection Cost Support Program Card
Chest Medicine Made Easy-Dr Deepu: FDA approves Injectable drug for uncontrolled Asthma
Attachment: Product Information: Reslizumab
CINQAIR® (reslizumab) Injection – About Asthma Control
Dosing and Administration
Drug Analysis: Cinqair - Research and Markets
CINQAIR® (reslizumab) Injection – About Asthma Control
Rx Item-Cinqair (Reslizumab) 10Mg/Ml Inj Sinle Use Vial 10Ml By Teva Respiratory
including co-pays, co-insurance, and deductibles.*
761033Orig1s000
hcp.cinqair.com
Subcutaneous Cinqair results add to Teva's troubles
video-placeholder-01.png
Cinqair (reslizumab)- Asthma- by Saro Arakelians, PharmD- Episode # 123 - YouTube
Help eligible, commercially insured patients save on out-of-pocket costs for CINQAIR*
Reslizumab | New Drug Approvals
test-placeholder-02.png
FDA Approves Cinqair To Treat Severe Asthma - Pharmacy Practice News
CINQAIR® (reslizumab) Injection – About CINQAIR
Israeli Pharma gets FDA Approval for Asthma Antibody
Clinical Efficacy Guidelines
Flopped trials dash Teva's hopes of battling GSK, AZ with subcutaneous Cinqair | Fierce Pharma
